Candel Therapeutics Stock (NASDAQ: CADL) stock price, news, charts, stock research, profile.
You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.
Other companies in Candel Therapeutics’s space includes: Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Tango Therapeutics (NASDAQ:TNGX).
Candel Therapeutics has a consensus price target of $10.25.
The stock price for Candel Therapeutics (NASDAQ: CADL) is $7.0599 last updated January 23, 2025 at 6:59 PM EST.
There are no upcoming dividends for Candel Therapeutics.
Candel Therapeutics’s Q4 earnings are confirmed for Thursday, March 27, 2025.
There is no upcoming split for Candel Therapeutics.
Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.